PsychedelicNewsBreaks – Microdose Psychedelic Insights Builds on IBN Partnership

February 8, 2022 15:36:24

Microdose Psychedelic Insights, a cutting-edge media company focused on promoting content, financial analysis, and engaging events designed to drive the psychedelics industry into the forefront of modern medicine, is building on its collaboration with InvestorBrandNetwork (“IBN”). IBN is a multifaceted financial news and publishing company. IBN will be supporting Microdose Psychedelic Insights throughout this year. A well-established leader within the psychedelic industry, Microdose is focused on providing educational insight to support the industry by distributing compelling sector content, financial analysis and engaging events. Microdose worked with IBN on its 2021 conference and looks forward to working with IBN as its

official media sponsor for upcoming 2022 conferences, including Microdose’s Psychedelic Capital series, the Molecular Masterclasses and the Wonderland Miami. “We are pleased to be continuing our collaboration with IBN for all of our events this year,” said Microdose president Patrick Moher in the press release. “Their powerful tools and communication solutions create a robust online presence, which strengthens the valuable connections our team creates between executives, industry experts and investors. We are looking forward to producing a standout series of events designed to drive the psychedelics industry into the forefront of modern medicine, and we believe that IBN’s assistance in helping us reach a broader investor audience will continue to be very helpful in heightening the success of our events.”

To view the full press release, visit https://ibn.fm/BROAb

About Microdose Psychedelic Insights
Microdose Psychedelic Insights is a guide to the psychedelic medicine industry. With a vision to shift the world’s perception of psychedelic medicine, the company distribute and create the most compelling content, financial analysis, engaging events, and ground-breaking education to drive the psychedelics industry to the forefront of modern medicine. For more information about the company, visit www.Microdose.buzz.

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.